Laurent Pharmaceuticals is a clinical stage biotech company founded in 2012, in Canada with a focus on modulating cell membrane lipids to address complex conditions arising from an unbalanced immune-inflammatory response. Their last investment of $2.70M in debt financing was secured on December 4th, 2019, with Gouvernement du Québec as the investor. Laurent Pharmaceuticals primarily operates in the biotechnology, healthcare, and pharmaceutical industries. With a commitment to addressing critical health challenges, the company's innovative approach and recent investment underscore its potential for significant growth and impact in the biotech sector.
General Information
Get notified when Laurent Pharmaceuticals moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Laurent Pharmaceuticals
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Canada Market
Biotechnology
About Laurent Pharmaceuticals
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | •••••• | 1 | •••• •••• | 04 Dec 2019 |
| Grant | •••••• | 1 |
|
31 Oct 2019 |
| Series A | •••••• | 1 |
|
14 Jun 2019 |
| Venture Round | •••••• | 6 |
|
25 Oct 2018 |
| Grant | •••••• | 1 |
|
14 Mar 2018 |
FAQ About Laurent Pharmaceuticals
We're actively collecting intelligence on Laurent Pharmaceuticals.
Track Laurent Pharmaceuticals to get notifiedDon't just browse. Track.
Signal Tracker monitors Laurent Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.